Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0002007919-25-000056
Filing Date
2025-05-14
Accepted
2025-05-14 16:09:27
Documents
64
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q inhibrx-20250331.htm   iXBRL 10-Q 770784
2 EX-31.1 exhibit311q12025.htm EX-31.1 10307
3 EX-31.2 exhibit312q12025.htm EX-31.2 10317
4 EX-32.1 exhibit321q12025.htm EX-32.1 5091
5 EX-32.2 exhibit322q12025.htm EX-32.2 5088
11 inhibrx-20250331_g1.jpg GRAPHIC 166858
12 inhibrx-20250331_g2.jpg GRAPHIC 162808
  Complete submission text file 0002007919-25-000056.txt   6047755

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inhibrx-20250331.xsd EX-101.SCH 39901
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inhibrx-20250331_cal.xml EX-101.CAL 63733
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inhibrx-20250331_def.xml EX-101.DEF 209300
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inhibrx-20250331_lab.xml EX-101.LAB 547397
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inhibrx-20250331_pre.xml EX-101.PRE 394679
67 EXTRACTED XBRL INSTANCE DOCUMENT inhibrx-20250331_htm.xml XML 552979
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Filer) CIK: 0002007919 (see all company filings)

EIN.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42031 | Film No.: 25945518
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)